Breakthrough Seizures
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects (NCT02721069) | Neurelis, Inc. | 2016-04-11 |
Track Breakthrough Seizures automatically
Every clearance here is in the API, with alerts when new ones post.